Breaking News Instant updates and real-time market news.

CVEO

Civeo

$1.32 /

-0.07 (-5.04%)

17:04
08/23/19
08/23
17:04
08/23/19
17:04

Civeo files $300M mixed securities shelf

CVEO Civeo
$1.32 /

-0.07 (-5.04%)

03/28/19 RBC Capital
Civeo initiated with a Sector Perform at RBC Capital
01/17/19 Stifel
Stifel lowers Oilfield Services and Equipment estimates
09/28/18 Stifel
Stifel reiterates Buy on Civeo as Shell seems close to starting LNG project
09/10/18 Stifel
Civeo initiated with a Buy at Stifel

TODAY'S FREE FLY STORIES

Syndicate
ViaSat files to sell 4.47M shares of common stock for holders  07:16
08/10/20
08/10
07:16
08/10/20
07:16
VSAT

ViaSat

$42.10 /

+3.48 (+9.01%)

 
ShowHide Related Items >><<
VSAT ViaSat
$42.10 /

+3.48 (+9.01%)

VSAT ViaSat
$42.10 /

+3.48 (+9.01%)

05/27/20 JPMorgan
ViaSat price target lowered to $60 from $70 at JPMorgan
05/20/20 William Blair
ViaSat defense contract renewal positive for shares, says William Blair
04/20/20 Barclays
Barclays upgrades ViaSat to Equal Weight on more balanced risk/reward
04/20/20 Barclays
ViaSat upgraded to Equal Weight from Underweight at Barclays
VSAT ViaSat
$42.10 /

+3.48 (+9.01%)

VSAT ViaSat
$42.10 /

+3.48 (+9.01%)

VSAT ViaSat
$42.10 /

+3.48 (+9.01%)

Hot Stocks
Morphic Holding to begin Phase 1 study of MORF-057 in Q3  07:16
08/10/20
08/10
07:16
08/10/20
07:16
MORF

Morphic Holding

$25.64 /

+1.24 (+5.08%)

 
ShowHide Related Items >><<
MORF Morphic Holding
$25.64 /

+1.24 (+5.08%)

MORF Morphic Holding
$25.64 /

+1.24 (+5.08%)

  • 12
    Feb
Earnings
Pieris Pharmaceuticals reports Q2 EPS (9c), consensus (17c) » 07:15
08/10/20
08/10
07:15
08/10/20
07:15
PIRS

Pieris Pharmaceuticals

$2.68 /

-0.06 (-2.19%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PIRS Pieris Pharmaceuticals
$2.68 /

-0.06 (-2.19%)

PIRS Pieris Pharmaceuticals
$2.68 /

-0.06 (-2.19%)

03/13/20 Baird
Baird upgrades Pieris Pharmaceuticals as pipeline updates expected
03/13/20 Baird
Pieris Pharmaceuticals upgraded to Outperform from Neutral at Baird
03/12/20 H.C. Wainwright
Increased visibility in 2020 expected for Pieris, says H.C. Wainwright
01/27/20 H.C. Wainwright
Pieris Pharmaceuticals price target raised to $9 from $7 at H.C. Wainwright
PIRS Pieris Pharmaceuticals
$2.68 /

-0.06 (-2.19%)

PIRS Pieris Pharmaceuticals
$2.68 /

-0.06 (-2.19%)

Hot Stocks
NantKwest, CBR by Generate Life Sciences announce collaboration » 07:15
08/10/20
08/10
07:15
08/10/20
07:15
NK

NantKwest

$10.54 /

+0.04 (+0.38%)

CBR by Generate Life…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NK NantKwest
$10.54 /

+0.04 (+0.38%)

NK NantKwest
$10.54 /

+0.04 (+0.38%)

07/08/20
Fly Intel: Top five analyst initiations
07/08/20 Piper Sandler
NantKwest initiated with an Overweight at Piper Sandler
  • 25
    Jun
NK NantKwest
$10.54 /

+0.04 (+0.38%)

NK NantKwest
$10.54 /

+0.04 (+0.38%)

Hot Stocks
Morphic Holding expects cash to be sufficient through end of 2022 » 07:15
08/10/20
08/10
07:15
08/10/20
07:15
MORF

Morphic Holding

$25.64 /

+1.24 (+5.08%)

As of June 30, 2020,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MORF Morphic Holding
$25.64 /

+1.24 (+5.08%)

MORF Morphic Holding
$25.64 /

+1.24 (+5.08%)

  • 12
    Feb
Earnings
Morphic Holding reports Q2 EPS (52c), consensus (56c) » 07:14
08/10/20
08/10
07:14
08/10/20
07:14
MORF

Morphic Holding

$25.64 /

+1.24 (+5.08%)

Reports Q2 revenue $7.7M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MORF Morphic Holding
$25.64 /

+1.24 (+5.08%)

  • 12
    Feb
Earnings
Avaya sees FY20 revenue $2.84B-$2.86B, consensus $2.78B » 07:14
08/10/20
08/10
07:14
08/10/20
07:14
AVYA

Avaya

$13.67 /

+0.255 (+1.90%)

Sees FY20 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVYA Avaya
$13.67 /

+0.255 (+1.90%)

AVYA Avaya
$13.67 /

+0.255 (+1.90%)

06/22/20 Rosenblatt
RingCentral price target raised to $315 from $270 at Rosenblatt
05/12/20 JPMorgan
Avaya price target raised to $16 from $11 at JPMorgan
05/11/20 Jefferies
Avaya Q2 comments a positive read-through for RingCentral, says Jefferies
04/23/20
Fly Intel: Top five analyst initiations
AVYA Avaya
$13.67 /

+0.255 (+1.90%)

Syndicate
Flagstar Bancorp files to sell 6M shares of common stock for holder » 07:14
08/10/20
08/10
07:14
08/10/20
07:14
FBC

Flagstar Bancorp

$32.78 /

+1.7 (+5.47%)

Flagstar Bancorp…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FBC Flagstar Bancorp
$32.78 /

+1.7 (+5.47%)

FBC Flagstar Bancorp
$32.78 /

+1.7 (+5.47%)

07/29/20 B. Riley FBR
Flagstar Bancorp price target raised to $41 from $33 at B. Riley FBR
06/17/20 Raymond James
Flagstar Bancorp upgraded to Strong Buy from Outperform at Raymond James
05/07/20 B. Riley FBR
Flagstar Bancorp price target raised to $30 from $27 at B. Riley FBR
02/26/20 Piper Sandler
Flagstar Bancorp upgraded to Overweight from Neutral at Piper Sandler
FBC Flagstar Bancorp
$32.78 /

+1.7 (+5.47%)

  • 30
    Oct
Earnings
Farmland Partners reports Q2 AFFO (4c), consensus (1c) » 07:13
08/10/20
08/10
07:13
08/10/20
07:13
FPI

Farmland Partners

$7.01 /

+0.255 (+3.78%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FPI Farmland Partners
$7.01 /

+0.255 (+3.78%)

FPI Farmland Partners
$7.01 /

+0.255 (+3.78%)

Earnings
Gogo not providing 2020 financial guidance » 07:13
08/10/20
08/10
07:13
08/10/20
07:13
GOGO

Gogo

$3.25 /

-0.03 (-0.91%)

Cites continued…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOGO Gogo
$3.25 /

-0.03 (-0.91%)

GOGO Gogo
$3.25 /

-0.03 (-0.91%)

07/07/20 Roth Capital
Roth Capital still bullish on Gogo, says new 3k foot floor highlights BA value
03/13/20 William Blair
Delta dual sourcing Wi-Fi potentially positive for ViaSat, says William Blair
03/02/20 William Blair
Gogo estimates lowered travel disruption from COVID-19 at William Blair
10/01/19 Morgan Stanley
Free WiFi poses Gogo risks, presents ViaSat opportunity, says Morgan Stanley
GOGO Gogo
$3.25 /

-0.03 (-0.91%)

GOGO Gogo
$3.25 /

-0.03 (-0.91%)

GOGO Gogo
$3.25 /

-0.03 (-0.91%)

Earnings
Avaya sees Q4 revenue $719M-$739M, consensus $694.13M » 07:13
08/10/20
08/10
07:13
08/10/20
07:13
AVYA

Avaya

$13.67 /

+0.255 (+1.90%)

Sees Q4 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVYA Avaya
$13.67 /

+0.255 (+1.90%)

AVYA Avaya
$13.67 /

+0.255 (+1.90%)

06/22/20 Rosenblatt
RingCentral price target raised to $315 from $270 at Rosenblatt
05/12/20 JPMorgan
Avaya price target raised to $16 from $11 at JPMorgan
05/11/20 Jefferies
Avaya Q2 comments a positive read-through for RingCentral, says Jefferies
04/23/20
Fly Intel: Top five analyst initiations
AVYA Avaya
$13.67 /

+0.255 (+1.90%)

Recommendations
Beyond Meat price target raised to $112 from $44 at Goldman Sachs » 07:13
08/10/20
08/10
07:13
08/10/20
07:13
BYND

Beyond Meat

$131.51 /

-1.06 (-0.80%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BYND Beyond Meat
$131.51 /

-1.06 (-0.80%)

BYND Beyond Meat
$131.51 /

-1.06 (-0.80%)

08/05/20 UBS
Beyond Meat price target raised to $110 from $105 at UBS
08/05/20 Piper Sandler
Piper calls Beyond Meat the Tesla of packaged food, ups price target
07/28/20
Fly Intel: Top five analyst initiations
07/28/20 Canaccord
Canaccord starts Beyond Meat at Hold on 'lofty valuation'
BYND Beyond Meat
$131.51 /

-1.06 (-0.80%)

BYND Beyond Meat
$131.51 /

-1.06 (-0.80%)

BYND Beyond Meat
$131.51 /

-1.06 (-0.80%)

BYND Beyond Meat
$131.51 /

-1.06 (-0.80%)

Earnings
Exterran reports Q2 EPS (97c), consenus (91c) » 07:13
08/10/20
08/10
07:13
08/10/20
07:13
EXTN

Exterran

$5.66 /

+0.265 (+4.91%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EXTN Exterran
$5.66 /

+0.265 (+4.91%)

EXTN Exterran
$5.66 /

+0.265 (+4.91%)

03/09/20 Evercore ISI
Exterran downgraded to In Line from Outperform at Evercore ISI
EXTN Exterran
$5.66 /

+0.265 (+4.91%)

Earnings
Gogo reports Q2 EPS ($1.05), consensus (88c) » 07:12
08/10/20
08/10
07:12
08/10/20
07:12
GOGO

Gogo

$3.25 /

-0.03 (-0.91%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOGO Gogo
$3.25 /

-0.03 (-0.91%)

GOGO Gogo
$3.25 /

-0.03 (-0.91%)

07/07/20 Roth Capital
Roth Capital still bullish on Gogo, says new 3k foot floor highlights BA value
03/13/20 William Blair
Delta dual sourcing Wi-Fi potentially positive for ViaSat, says William Blair
03/02/20 William Blair
Gogo estimates lowered travel disruption from COVID-19 at William Blair
10/01/19 Morgan Stanley
Free WiFi poses Gogo risks, presents ViaSat opportunity, says Morgan Stanley
GOGO Gogo
$3.25 /

-0.03 (-0.91%)

GOGO Gogo
$3.25 /

-0.03 (-0.91%)

GOGO Gogo
$3.25 /

-0.03 (-0.91%)

Earnings
Avaya reports Q3 EPS 8c vs. ($5.70) last year » 07:12
08/10/20
08/10
07:12
08/10/20
07:12
AVYA

Avaya

$13.67 /

+0.255 (+1.90%)

Reports Q3 revenue $721M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVYA Avaya
$13.67 /

+0.255 (+1.90%)

AVYA Avaya
$13.67 /

+0.255 (+1.90%)

06/22/20 Rosenblatt
RingCentral price target raised to $315 from $270 at Rosenblatt
05/12/20 JPMorgan
Avaya price target raised to $16 from $11 at JPMorgan
05/11/20 Jefferies
Avaya Q2 comments a positive read-through for RingCentral, says Jefferies
04/23/20
Fly Intel: Top five analyst initiations
AVYA Avaya
$13.67 /

+0.255 (+1.90%)

Recommendations
UPS price target raised to $162 from $150 at UBS » 07:11
08/10/20
08/10
07:11
08/10/20
07:11
UPS

UPS

$156.84 /

+11.51 (+7.92%)

UBS analyst Thomas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UPS UPS
$156.84 /

+11.51 (+7.92%)

UPS UPS
$156.84 /

+11.51 (+7.92%)

08/06/20 Oppenheimer
UPS price target raised to $153 from $106 at Oppenheimer
08/03/20 Standpoint Research
UPS downgraded to Hold from Buy at Standpoint Research
08/03/20 Stephens
UPS price target raised to $150 from $105 at Stephens
07/31/20 BMO Capital
UPS price target raised to $115 from $95 at BMO Capital
UPS UPS
$156.84 /

+11.51 (+7.92%)

UPS UPS
$156.84 /

+11.51 (+7.92%)

UPS UPS
$156.84 /

+11.51 (+7.92%)

UPS UPS
$156.84 /

+11.51 (+7.92%)

Hot Stocks
Voyager Therapeutics announces anticipated upcoming milestones » 07:11
08/10/20
08/10
07:11
08/10/20
07:11
VYGR

Voyager Therapeutics

$11.24 /

+0.24 (+2.18%)

VY-AADC for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VYGR Voyager Therapeutics
$11.24 /

+0.24 (+2.18%)

VYGR Voyager Therapeutics
$11.24 /

+0.24 (+2.18%)

08/05/20 Benchmark
Voyager 'break up' with AbbVie has no impact on valuation, says Benchmark
08/04/20 H.C. Wainwright
Voyager Therapeutics price target lowered to $14 from $18 at H.C. Wainwright
03/30/20 Nomura Instinet
Voyager Therapeutics price target lowered to $16 from $37 at Nomura Instinet
03/19/20
Fly Intel: Top five analyst initiations
VYGR Voyager Therapeutics
$11.24 /

+0.24 (+2.18%)

Earnings
Ceva reports Q2 non-GAAP EPS 12c, consensus 4c » 07:10
08/10/20
08/10
07:10
08/10/20
07:10
CEVA

Ceva

$42.01 /

+0.67 (+1.62%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CEVA Ceva
$42.01 /

+0.67 (+1.62%)

CEVA Ceva
$42.01 /

+0.67 (+1.62%)

07/16/20 Roth Capital
Ceva price target raised to $50 from $40 at Roth Capital
06/04/20 Northland
Ceva downgraded to Market Perform from Outperform at Northland
03/30/20 Northland
Ceva upgraded to Outperform from Market Perform at Northland
02/18/20 Roth Capital
Ceva price target raised to $40 from $35 at Roth Capital
CEVA Ceva
$42.01 /

+0.67 (+1.62%)

Earnings
Xeris Pharmaceuticals reports Q2 EPS (63c), consensus (73c) » 07:10
08/10/20
08/10
07:10
08/10/20
07:10
XERS

Xeris Pharmaceuticals

$3.36 /

+0.17 (+5.33%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XERS Xeris Pharmaceuticals
$3.36 /

+0.17 (+5.33%)

XERS Xeris Pharmaceuticals
$3.36 /

+0.17 (+5.33%)

04/23/20 Mizuho
Xeris Pharmaceuticals price target lowered to $14 from $18 at Mizuho
02/20/20 Mizuho
Xeris Pharmaceuticals price target lowered to $18 from $22 at Mizuho
02/18/20
Fly Intel: Top five analyst initiations
02/18/20 Piper Sandler
Xeris Pharmaceuticals initiated with an Overweight at Piper Sandler
XERS Xeris Pharmaceuticals
$3.36 /

+0.17 (+5.33%)

  • 26
    Jun
  • 12
    Feb
XERS Xeris Pharmaceuticals
$3.36 /

+0.17 (+5.33%)

Hot Stocks
Voyager Therapeutics expects cash to be sufficient into mid-2022 » 07:09
08/10/20
08/10
07:09
08/10/20
07:09
VYGR

Voyager Therapeutics

$11.24 /

+0.24 (+2.18%)

Based on the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VYGR Voyager Therapeutics
$11.24 /

+0.24 (+2.18%)

VYGR Voyager Therapeutics
$11.24 /

+0.24 (+2.18%)

08/05/20 Benchmark
Voyager 'break up' with AbbVie has no impact on valuation, says Benchmark
08/04/20 H.C. Wainwright
Voyager Therapeutics price target lowered to $14 from $18 at H.C. Wainwright
03/30/20 Nomura Instinet
Voyager Therapeutics price target lowered to $16 from $37 at Nomura Instinet
03/19/20
Fly Intel: Top five analyst initiations
VYGR Voyager Therapeutics
$11.24 /

+0.24 (+2.18%)

Earnings
Black Knight sees FY20 adjusted EPS 1.94-$1.99, consensus $1.93 » 07:09
08/10/20
08/10
07:09
08/10/20
07:09
BKI

Black Knight

$76.74 /

+1.09 (+1.44%)

Sees FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BKI Black Knight
$76.74 /

+1.09 (+1.44%)

BKI Black Knight
$76.74 /

+1.09 (+1.44%)

07/23/20 Keefe Bruyette
Black Knight upgraded to Outperform from Market Perform at Keefe Bruyette
06/29/20 Zelman
Black Knight added as Buy to Top Idea Basket at Zelman
05/06/20 Stephens
Stephens names Black Knight as a Best Idea
05/06/20 Wells Fargo
Black Knight price target raised to $85 from $80 at Wells Fargo
BKI Black Knight
$76.74 /

+1.09 (+1.44%)

  • 17
    Jun
Earnings
Voyager Therapeutics reports Q2 EPS (23c), consensus (72c) » 07:09
08/10/20
08/10
07:09
08/10/20
07:09
VYGR

Voyager Therapeutics

$11.24 /

+0.24 (+2.18%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VYGR Voyager Therapeutics
$11.24 /

+0.24 (+2.18%)

VYGR Voyager Therapeutics
$11.24 /

+0.24 (+2.18%)

08/05/20 Benchmark
Voyager 'break up' with AbbVie has no impact on valuation, says Benchmark
08/04/20 H.C. Wainwright
Voyager Therapeutics price target lowered to $14 from $18 at H.C. Wainwright
03/30/20 Nomura Instinet
Voyager Therapeutics price target lowered to $16 from $37 at Nomura Instinet
03/19/20
Fly Intel: Top five analyst initiations
VYGR Voyager Therapeutics
$11.24 /

+0.24 (+2.18%)

Initiation
Concrete Pumping initiated with a Neutral at UBS » 07:09
08/10/20
08/10
07:09
08/10/20
07:09
BBCP

Concrete Pumping

$4.17 /

+0.24 (+6.11%)

UBS analyst Steven Fisher…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBCP Concrete Pumping
$4.17 /

+0.24 (+6.11%)

BBCP Concrete Pumping
$4.17 /

+0.24 (+6.11%)

06:35 Today UBS
Concrete Pumping initiated with a Neutral at UBS
04/03/20 B. Riley FBR
Concrete Pumping downgraded on weakening markets at B. Riley FBR
04/03/20 B. Riley FBR
Concrete Pumping downgraded to Neutral from Buy at B. Riley FBR
03/24/20 Baird
Concrete Pumping downgraded to Neutral from at Baird
BBCP Concrete Pumping
$4.17 /

+0.24 (+6.11%)

BBCP Concrete Pumping
$4.17 /

+0.24 (+6.11%)

Earnings
Apyx Medical not providing FY20 guidance 'at this time' » 07:08
08/10/20
08/10
07:08
08/10/20
07:08
APYX

Apyx Medical

$4.90 /

-0.08 (-1.61%)

Apyx Medical said in its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APYX Apyx Medical
$4.90 /

-0.08 (-1.61%)

APYX Apyx Medical
$4.90 /

-0.08 (-1.61%)

06/22/20 Piper Sandler
Apyx Medical's expanded international sale 'important', says Piper Sandler
03/17/20 Piper Sandler
Apyx Medical price target lowered to $7 from $10 at Piper Sandler
01/13/20 JMP Securities
Apyx Medical shares likely to continue to appreciate, says JMP Securities
11/11/19 Piper Jaffray
Apyx Medical price target raised to $10 from $8 at Piper Jaffray
APYX Apyx Medical
$4.90 /

-0.08 (-1.61%)

APYX Apyx Medical
$4.90 /

-0.08 (-1.61%)

Initiation
PolyPid initiated with a Buy at Alliance Global Partners » 07:08
08/10/20
08/10
07:08
08/10/20
07:08
PYPD

PolyPid

$14.36 /

+0.15 (+1.06%)

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PYPD PolyPid
$14.36 /

+0.15 (+1.06%)

PYPD PolyPid
$14.36 /

+0.15 (+1.06%)

07/21/20 Raymond James
PolyPid initiated with an Outperform at Raymond James
07/21/20 Raymond James
PolyPid initiated with an Outperform at Raymond James
07/21/20 BMO Capital
PolyPid initiated with an Outperform at BMO Capital
07/21/20 Barclays
PolyPid initiated with an Overweight at Barclays
  • 26
    Jun
PYPD PolyPid
$14.36 /

+0.15 (+1.06%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.